Cargando…
A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
The search for tumor-specific antigens (TSAs) has considerably accelerated during the past decade due to the improvement of proteogenomic detection methods. This provides new opportunities for the development of novel antitumoral immunotherapies to mount an efficient T cell response against one or m...
Autores principales: | Minati, Robin, Perreault, Claude, Thibault, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793940/ https://www.ncbi.nlm.nih.gov/pubmed/33424836 http://dx.doi.org/10.3389/fimmu.2020.583287 |
Ejemplares similares
-
The Origin and Immune Recognition of Tumor-Specific Antigens
por: Apavaloaei, Anca, et al.
Publicado: (2020) -
Discovery and characterization of actionable tumor antigens
por: Ehx, Grégory, et al.
Publicado: (2019) -
The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy
por: Hardy, Marie-Pierre, et al.
Publicado: (2019) -
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
por: Cuevas, Maria Virginia Ruiz, et al.
Publicado: (2023) -
Strategies Towards Antigen-Specific Treatments for Membranous Nephropathy
por: Köllner, Sarah M. S., et al.
Publicado: (2022)